Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2

Wu,Yunyan; Sato,Hidenobu; Suzuki,Takahiro; Yoshizawa,Tadashi; Morohashi,Satoko; Seino,Hiroko; Kawamoto,Takeshi; Fujimoto,Katsumi; Kato,Yukio; Kijima,Hiroshi

doi:10.3892/ijmm.2014.2042

Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2

Authors:
- Yunyan Wu
- Hidenobu Sato
- Takahiro Suzuki
- Tadashi Yoshizawa
- Satoko Morohashi
- Hiroko Seino
- Takeshi Kawamoto
- Katsumi Fujimoto
- Yukio Kato
- Hiroshi Kijima
View Affiliations

Affiliations: Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan, Department of Dental and Medical Biochemistry, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima 734-8553, Japan
Published online on: December 17, 2014 https://doi.org/10.3892/ijmm.2014.2042
Pages: 815-820

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Differentiated embryonic chondrocyte expressed gene 1 (DEC1; BHLHE40/Stra13/Sharp2) and differentiated embryonic chondrocyte expressed gene 2 (DEC2; BHLHE41/Sharp1) are basic helix-loop-helix (bHLH) transcriptional factors that are involved in the regulation of cell differentiation, circadian rhythms, response to hypoxia and carcinogenesis. Previous studies have demonstrated that the expression of DECs is induced under hypoxic conditions in various normal and cancer cell lines. In the present study, using RT-qPCR and western blot analysis, we demonstrated that hypoxia induced the expression of DEC1 and DEC2 in MCF-7 human breast cancer cells; their expression levels reached a peak at different time points. In particular, we found that the expression pattern of the hypoxia-inducible factor (HIF)-1α protein was similar to DEC1, and that of the HIF-2α protein was identical to that of DEC2. The knockdown of HIF-2α using siRNA suppressed the phosphorylation of Akt, as well as the expression of DEC2 and c-Myc. Hypoxia failed to affect the expression of DEC2 and c-Myc when the PI3K/Akt signaling pathway was blocked. In addition, the overexpression of DEC1 and DEC2 was induced by transfecting the cells with a pcDNA vector. The overexpression of DEC2, but not that of DEC1, increased the proliferation of the MCF-7 cells under both normoxic and hypoxic conditions. Concomitantly, the expression of c-Myc was upregulated by exposure to hypoxia and by the overexpression of DEC2. In conclusion, DEC2 participates in hypoxia-induced cell proliferation by functioning as a target gene of the PI3K/Akt signaling pathway and regulating the expression of c-Myc.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
2	Favaro E, Lord S, Harris AL and Buffa FM: Gene expression and hypoxia in breast cancer. Genome Med. 3:552011. View Article : Google Scholar : PubMed/NCBI
3	Fyles A, Milosevic M, Hedley D, et al: Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol. 20:680–687. 2002. View Article : Google Scholar : PubMed/NCBI
4	Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:4509–4515. 1996.PubMed/NCBI
5	Jubb AM, Buffa FM and Harris AL: Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J Cell Mol Med. 14:18–29. 2010. View Article : Google Scholar
6	Nordsmark M, Bentzen SM, Rudat V, et al: Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 77:18–24. 2005. View Article : Google Scholar : PubMed/NCBI
7	Vaupel P and Mayer A: Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
8	Hu CJ, Sataur A, Wang L, Chen H and Simon MC: The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell. 18:4528–4542. 2007. View Article : Google Scholar : PubMed/NCBI
9	Keith B, Johnson RS and Simon MC: HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 12:9–22. 2012.
10	Loboda A, Jozkowicz A and Dulak J: HIF-1 versus HIF-2–is one more important than the other? Vascul Pharmacol. 56:245–251. 2012. View Article : Google Scholar : PubMed/NCBI
11	Packham G and Cleveland JL: c-Myc and apoptosis. Biochim Biophys Acta. 1242:11–28. 1995.PubMed/NCBI
12	Hoffman B and Liebermann DA: The proto-oncogene c-myc and apoptosis. Oncogene. 17:3351–3357. 1998. View Article : Google Scholar
13	Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11. 1999.
14	Dang CV, Resar LM, Emison E, et al: Function of the c-Myc oncogenic transcription factor. Exp Cell Res. 253:63–77. 1999. View Article : Google Scholar : PubMed/NCBI
15	Elend M and Eilers M: Cell growth: downstream of Myc - to grow or to cycle? Curr Biol. 9:R936–R938. 1999. View Article : Google Scholar : PubMed/NCBI
16	Prendergast GC: Mechanisms of apoptosis by c-Myc. Oncogene. 18:2967–2987. 1999. View Article : Google Scholar : PubMed/NCBI
17	Wu Y, Sato F, Bhawal UK, et al: Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells. Int J Mol Med. 27:491–495. 2011.PubMed/NCBI
18	Liu Y, Sato F, Kawamoto T, et al: Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells. Genes Cells. 15:315–325. 2010. View Article : Google Scholar : PubMed/NCBI
19	Liang J, Zubovitz J, Petrocelli T, et al: PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med. 8:1153–1160. 2002. View Article : Google Scholar : PubMed/NCBI
20	Gordan JD, Thompson CB and Simon MC: HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 12:108–113. 2007. View Article : Google Scholar : PubMed/NCBI
21	Bhawal UK, Sato F, Arakawa Y, et al: Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1. J Pathol. 224:420–429. 2011. View Article : Google Scholar : PubMed/NCBI
22	Hamaguchi H, Fujimoto K, Kawamoto T, et al: Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system. Biochem J. 382:43–50. 2004. View Article : Google Scholar : PubMed/NCBI
23	Fujimoto K, Hamaguchi H, Hashiba T, et al: Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements. Int J Mol Med. 19:925–932. 2007.PubMed/NCBI
24	Nakashima A, Kawamoto T, Honda KK, et al: DEC1 modulates the circadian phase of clock gene expression. Mol Cell Biol. 28:4080–4092. 2008. View Article : Google Scholar : PubMed/NCBI
25	Zhang L and Li QQ: Embryo-chondrocyte expressed gene 1, downregulating hypoxia-inducible factor 1alpha, is another marker of lung tumor hypoxia. Acta Pharmacol Sin. 28:549–558. 2007. View Article : Google Scholar : PubMed/NCBI
26	Zawel L, Yu J, Torrance CJ, et al: DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities. Proc Natl Acad Sci USA. 99:2848–2853. 2002. View Article : Google Scholar : PubMed/NCBI
27	Ivanova AV, Ivanov SV, Zhang X, Ivanov VN, Timofeeva OA and Lerman MI: STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets. J Mol Biol. 340:641–653. 2004. View Article : Google Scholar : PubMed/NCBI
28	Boudjelal M, Taneja R, Matsubara S, Bouillet P, Dolle P and Chambon P: Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev. 11:2052–2065. 1997. View Article : Google Scholar : PubMed/NCBI
29	Yamada K, Kawata H, Shou Z, Mizutani T, Noguchi T and Miyamoto K: Insulin induces the expression of the SHARP-2/Stra13/DEC1 gene via a phosphoinositide 3-kinase pathway. J Biol Chem. 278:30719–30724. 2003. View Article : Google Scholar : PubMed/NCBI
30	Honma S, Kawamoto T, Takagi Y, et al: Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 419:841–844. 2002. View Article : Google Scholar : PubMed/NCBI
31	Yamada K and Miyamoto K: Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. Front Biosci. 10:3151–3171. 2005. View Article : Google Scholar : PubMed/NCBI
32	Loboda A, Jozkowicz A and Dulak J: HIF-1 and HIF-2 transcription factors - similar but not identical. Mol Cells. 29:435–442. 2010. View Article : Google Scholar : PubMed/NCBI
33	Koh MY and Powis G: Passing the baton: the HIF switch. Trends Biochem Sci. 37:364–372. 2012. View Article : Google Scholar : PubMed/NCBI
34	Bishop JM: Retroviruses and cancer genes. Adv Cancer Res. 37:1–32. 1982. View Article : Google Scholar : PubMed/NCBI
35	Liao DJ and Dickson RB: c-Myc in breast cancer. Endocr Relat Cancer. 7:143–164. 2000. View Article : Google Scholar : PubMed/NCBI
36	Weng W, Yang Q, Huang M, et al: c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma. Biochem Biophys Res Commun. 405:278–284. 2011. View Article : Google Scholar : PubMed/NCBI
37	Dang CV, O’Donnell KA, Zeller KI, Nguyen T, Osthus RC and Li F: The c-Myc target gene network. Semin Cancer Biol. 16:253–264. 2006. View Article : Google Scholar : PubMed/NCBI
38	Adhikary S and Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol. 6:635–645. 2005. View Article : Google Scholar : PubMed/NCBI
39	Zhang H, Gao P, Fukuda R, et al: HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell. 11:407–420. 2007. View Article : Google Scholar : PubMed/NCBI
40	Corn PG, Ricci MS, Scata KA, et al: Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther. 4:1285–1294. 2005. View Article : Google Scholar : PubMed/NCBI
41	Wu Y, Sato F, Yamada T, et al: The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer. Int J Oncol. 41:1337–1346. 2012.PubMed/NCBI